학술논문

An unusual outcome of papillary renal cell carcinoma with lung metastases: a case report and review of literature
Case Reports
Document Type
Academic Journal
Source
African Journal of Urology. December 2021, Vol. 27 Issue 1
Subject
Care and treatment
Development and progression
Genetic aspects
Renal cell carcinoma -- Care and treatment -- Genetic aspects -- Development and progression
Cancer metastasis -- Care and treatment -- Genetic aspects -- Development and progression
Metastasis -- Care and treatment -- Genetic aspects -- Development and progression
Carcinoma, Renal cell -- Care and treatment -- Genetic aspects -- Development and progression
Language
English
ISSN
1110-5704
Abstract
Author(s): Emmanuel Owusu Ofori [sup.1], Baba Alhaji Bin Alhassan [sup.1], Edwina Ayaaba Ayabilah [sup.1], Patrick Opoku Manu Maison [sup.2], Alvin Asante-Asamani [sup.1], Henry Atawura [sup.2], Ganiyu Adebisi Rahman [sup.2], Patrick [...]
Background Renal cell carcinoma (RCC) is a heterogeneous group of malignant epithelial tumors of the kidney. It accounts for more than 90% of all kidney cancers. However, papillary RCC is the second most common histologic subtype representing 10-15% of all RCCs. The mean age of presentation for papillary RCC ranges between 59 and 63 years but more importantly when RCC is diagnosed at a younger age, the possibility of an underlying hereditary kidney cancer syndrome should be considered. RCC potentially metastasizes to many different organs with lung being the commonest site accounting for 45.2%. The treatment for metastatic RCC is mostly multimodal for most patients. However, patients with untreated pulmonary metastases have been observed to have very poor prognosis with a 5-year overall survival rate of only 5% or even less and thus the need to report on the unusual outcome of our patient who had a metastatic disease. Case presentation The present study reports a papillary renal cell carcinoma with multiple lung metastases in a 31-year-old woman who presented with progressive right flank mass and pain with no chest symptoms. She underwent cytoreductive radical nephrectomy via a right subcostal incision. Patient, however, did not undergo metastasectomy nor palliative systemic therapy and was seen 5 years post-nephrectomy. Conclusion Our patient with metastatic RCC, without undergoing metastasectomy nor palliative systemic therapy, remained stable with 5-year progression-free survival post-cytoreductive nephrectomy.